Patent · US Active

Arf6 inhibitors and methods of synthesis and use thereof

US10849901B2 · kind B2 · utility

0Cited by

5References

12Claims

0Family size

Assignees

Navigen, Inc. · US
University of Utah Research Foundation · US

Inventors

Kirill Ostanin · Salt Lake City, US
Mark Shenderovich · Salt Lake City, US
Ashok Bajji · Hyderabad, IN
Christopher Cioffi · Troy, US
Neil Moss · Ridgefield, US
Hariprasad Vankayalapati · Draper, US
Dean Li · Salt Lake City, US

Key dates

Filing date	May 27, 2015
Grant date	Dec 1, 2020
Priority date	—
Expiry date	May 27, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compounds and methods for inhibiting Arf6. Pharmaceutical compositions and methods for treating a subject with an inhibitor of Arf6 are also disclosed herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.